Company intelligence / Profile preview

First Light Diagnostics

Chelmsford, Massachusetts, United Statesfirstlightdx.com ↗

Ownership: Private
Employees: ~26
Development stage: Commercial

Overview

First Light Diagnostics has developed the proprietary MultiPath platform, which enables rapid and sensitive detection of infectious disease pathogens and provides antimicrobial susceptibility test results in hours rather than days. This technology aims to improve patient outcomes by enabling earlier targeted therapy for life-threatening, hospital-acquired infections and combating antibiotic resistance. The company is preparing for commercial launch; no clinical trial data or regulatory approvals are specified in public sources.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic equipment (specifically rapid diagnostic platforms)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on First Light Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Light Diagnostics.

Explore the full profile